Delivery Order SPE2DB22D2206-SPE2DB25FJB69
Award Date 7/25/25
Potential Completion Date 8/15/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,308.18 for 400 mg Benlysta vials on July 28, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the major pharmaceutical distributor for medical supplies supporting federal healthcare needs. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $18,147.78 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of September 4, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single transaction under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,944.43 on July 21, 2025, for the supply of Benlysta 400 mg vials to support federal medical procurement needs. The contract, which is non-set-aside and competitively awarded, is structured as a firm fixed price delivery order with an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,629.64 by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Benlysta 400 mg vials with an ultimate completion date of August 19, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The delivery order, valued at $15,114.00, is for the supply of Benlysta 400 mg vials, a specialty pharmaceutical product. The delivery order is a firm fixed price contract with an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor and...
- The Defense Logistics Agency (DLA) awarded a $10,518.48 delivery order to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials, with an ultimate completion date of August 12, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Benlysta 200 mg/mL syringes, with a ceiling value of $12,305.60. This is a firm fixed price delivery order with an ultimate completion date of September 5, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through competitive procurement with no set-aside designation....
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,259.50 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide BENLYSTA 400 mg vials. The contract has a completion date of February 27, 2024. This delivery order is part of Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Benlysta 200 mg/mL auto-injector with a ceiling value of $3,082.67. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with the company serving as the prime contractor on this delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,515.15 firm fixed-price delivery order is for the supply of 400 mg vials of the drug Benlysta, with a completion date of January 6, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...